A Study of LY2584702 With Erlotinib or Everolimus in Participants With Solid Tumors

Clinical trial NCT01115803 · TERMINATED

Trial details

NCT number: NCT01115803
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastases, Neoplasm Carcinoma, Non-small Cell Lung Renal Cell Carcinoma Neuroendocrine Tumors

Start date: 2010-03-01
Primary completion: 2011-06-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.